Intco Medical Technology Co Ltd
SZSE:300677

Watchlist Manager
Intco Medical Technology Co Ltd Logo
Intco Medical Technology Co Ltd
SZSE:300677
Watchlist
Price: 57.78 CNY 0.87% Market Closed
Market Cap: ¥37.8B

P/B

2.1
Current
111%
More Expensive
vs 3-y average of 1

Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.

P/B
2.1
=
Market Cap
¥27.2B
/
Total Equity
¥18.2B

Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.

P/B
2.1
=
Market Cap
¥27.2B
/
Total Equity
¥18.2B

Valuation Scenarios

Intco Medical Technology Co Ltd is trading above its 3-year average

If P/B returns to its 3-Year Average (1), the stock would be worth ¥27.34 (53% downside from current price).

Statistics
Positive Scenarios
2/4
Maximum Downside
-53%
Maximum Upside
+18%
Average Downside
19%
Scenario P/B Value Implied Price Upside/Downside
Current Multiple 2.1 ¥57.78
0%
3-Year Average 1 ¥27.34
-53%
5-Year Average 1 ¥28.46
-51%
Industry Average 2.3 ¥62.9
+9%
Country Average 2.4 ¥67.91
+18%

Forward P/B
Today’s price vs future total equity

Not enough data available to calculate forward P/B

Peer Comparison

All Multiples
P/B
P/E
All Countries
Close
P/E Multiple
Earnings Growth PEG
CN
Intco Medical Technology Co Ltd
SZSE:300677
Average P/E: 31.7
22.2
12%
1.9
JP
Hoya Corp
TSE:7741
39.3
15%
2.6
US
M
Medline Inc
NASDAQ:MDLN
Not Available
30%
N/A
CH
Alcon AG
SIX:ALC
35.9
32%
1.1
DK
Coloplast A/S
CSE:COLO B
22.5
21%
1.1
US
Align Technology Inc
NASDAQ:ALGN
29.9
34%
0.9
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -37.9 N/A N/A
UK
ConvaTec Group PLC
LSE:CTEC
31.3
41%
0.8
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
23
9%
2.6
JP
A
Asahi Intecc Co Ltd
TSE:7747
49.5
40%
1.2
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -15 N/A N/A

Market Distribution

In line with most companies in China
Percentile
43nd
Based on 7 605 companies
43nd percentile
2.1
Low
0 — 1.5
Typical Range
1.5 — 3.9
High
3.9 —
Distribution Statistics
China
Min 0
30th Percentile 1.5
Median 2.4
70th Percentile 3.9
Max 1 172 445.9

Intco Medical Technology Co Ltd
Glance View

Market Cap
37.8B CNY
Industry
Health Care

In the bustling industrial landscape of China, Intco Medical Technology Co., Ltd. has carved a distinctive niche as a significant player in the production and global distribution of disposable medical products. Established in 2009, the company has orchestrated its growth strategy by focusing on the manufacture of essential medical consumables like gloves, face masks, thermal plastics, and non-woven products. Intco's operations are adeptly integrated, with facilities strategically located to optimize manufacturing efficiencies and logistical ease, facilitating swift distribution to over 100 countries. This strategic footprint ensures that products are rapidly dispatched to meet the ever-increasing demands of global healthcare markets. Driving the company’s financial engine is its diversified product portfolio, tailored to cater to a wide array of healthcare needs, from hospitals to individual consumers who prioritize personal health safety. The company monetizes its offerings through a robust sales network, leveraging both direct sales channels and partnerships with global distributors. While the COVID-19 pandemic played a role in increasing demand for personal protective equipment, Intco has sustained its profitability through a commitment to quality and innovation, continuously expanding its research and development initiatives. By maintaining a balance between high-volume production and stringent quality control, Intco Medical Technology thrives as a cornerstone in the healthcare supply chain, adeptly navigating the dynamics of a rapidly evolving industry.

Intrinsic Value
18.98 CNY
Overvaluation 67%
Intrinsic Value
Price ¥57.78
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett